Enovis CORP (ENOV)
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Medical - Devices
Enovis Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | 27.59 | 28.73 | 26.74 | 28.54 | 1,614,483 |
| Nov 6, 2026 | 27.24 | 27.67 | 26.62 | 27.16 | 2,304,738 |
| Nov 5, 2026 | 28.43 | 29.89 | 26.89 | 28.62 | 5,591,867 |
| Nov 4, 2026 | 21.77 | 24.61 | 21.77 | 24.42 | 3,805,488 |
| Nov 3, 2026 | 20.63 | 21.53 | 20.34 | 20.89 | 1,944,504 |
| Nov 2, 2026 | 20.37 | 21.67 | 20.37 | 20.62 | 2,493,220 |
| Oct 30, 2026 | 22.17 | 22.26 | 19.83 | 19.91 | 2,524,736 |
| Oct 29, 2026 | 22.12 | 22.84 | 21.88 | 22.81 | 1,296,405 |
| Oct 28, 2026 | 21.49 | 22.29 | 21.45 | 21.91 | 1,175,548 |
| Oct 27, 2026 | 21.14 | 22.13 | 20.61 | 21.54 | 2,380,840 |
| Oct 26, 2026 | 21.10 | 21.27 | 20.74 | 21.16 | 905,914 |
| Oct 23, 2026 | 21.39 | 21.70 | 20.86 | 21.08 | 954,300 |
| Oct 22, 2026 | 20.99 | 21.73 | 20.79 | 21.59 | 1,295,357 |
| Oct 21, 2026 | 20.66 | 21.49 | 20.48 | 20.81 | 1,204,040 |
| Oct 20, 2026 | 20.00 | 20.89 | 19.89 | 20.69 | 1,185,247 |
| Oct 19, 2026 | 19.53 | 20.15 | 19.43 | 19.87 | 1,616,611 |
| Oct 16, 2026 | 19.64 | 19.78 | 19.36 | 19.59 | 1,452,907 |
| Oct 15, 2026 | 18.76 | 19.44 | 18.42 | 19.35 | 1,294,435 |
| Oct 14, 2026 | 18.74 | 18.85 | 18.23 | 18.57 | 1,142,268 |
| Oct 13, 2026 | 18.50 | 19.12 | 18.18 | 18.99 | 1,405,755 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 958 | -- | Sep 30, 2026 | |
| Chief Executive Officer | Purchase | 13.0K | $249.6K | Sep 4, 2026 | |
| Chief Administrative Officer | Purchase | 2.7K | $50.0K | Sep 4, 2026 | |
| Chief Administrative Officer | Purchase | 5.1K | $100.0K | Sep 3, 2026 | |
| Chief Administrative Officer | Purchase | 2.5K | $49.9K | Sep 2, 2026 | |
| Director | Grant/Award | 846 | -- | Jun 30, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 10.3M | 17.8% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Jul 2026 | 9.2M | 15.9% | 13G |
AMERICAN CENTURY COMPANIES INC | 6.1M | 10.6% | 13F |
American Century Investment Management, Inc. · also on 13F· joint filing· may incl. warrants· filed Jul 2026 | 6.1M | 10.6% | 13G |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.9M | 6.8% | 13F |
Rubric Capital Management LP | 3.9M | 6.8% | 13F |
Rubric Capital Management LP · also on 13F· joint filing· may incl. warrants· filed Sep 2026 | 3.9M | 6.8% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | 4.3% | 13F |
STATE STREET CORP | 2.5M | 4.3% | 13F |
DIMENSIONAL FUND ADVISORS LP | 2.3M | 4.1% | 13F |
Insiders
- Ortiz ChristineDirector
- McDonald DamienChief Executive Officer
- Engert OliverChief Administrative Officer
- Bodem Barbara W.Director
- Shirley BradyDirector
- Okala PhilipDirector
- Lalor Angela SDirector
- PERFALL A CLAYTONDirector
- Kelly LiamDirector
- Wienbar Sharon LDirector
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries.
The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment.
Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
13F filers report 66.21M shares, more than the 57.69M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
30d Avg
1.83M
60d Avg
1.84M
90d Avg
1.68M